Lipid-based formulations of antisense oligonucleotides for systemic delivery applications

被引：0
作者：
Semple, SC [1 ]
Klimuk, SK
Harasym, TO
Hope, MJ
机构：
[1] Inex Pharmaceut Corp, Burnaby, BC V5J 5J8, Canada
[2] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada
来源：
ANTISENSE TECHNOLOGY, PT A | 2000年 / 313卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：322 / 341
页数：20
相关论文
共 36 条
[1]  
Agrawal S, 1997, CIBA F SYMP, V209, P60
[2]   STABILITY OF ANTISENSE DNA OLIGODEOXYNUCLEOTIDE ANALOGS IN CELLULAR-EXTRACTS AND SERA [J].
AKHTAR, S ;
KOLE, R ;
JULIANO, RL .
LIFE SCIENCES, 1991, 49 (24) :1793-1801
[3]   INTERACTIONS OF ANTISENSE DNA OLIGONUCLEOTIDE ANALOGS WITH PHOSPHOLIPID-MEMBRANES (LIPOSOMES) [J].
AKHTAR, S ;
BASU, S ;
WICKSTROM, E ;
JULIANO, RL .
NUCLEIC ACIDS RESEARCH, 1991, 19 (20) :5551-5559
[4]  
BALLY MB, 1993, LIPOSOME TECHNOLOGY, P27
[5]   Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol) lipids [J].
Bradley, AJ ;
Devine, DV ;
Ansell, SM ;
Janzen, J ;
Brooks, DE .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1998, 357 (02) :185-194
[6]  
BROWN DA, 1994, J BIOL CHEM, V269, P26801
[7]  
CHONN A, 1991, J IMMUNOL, V146, P4234
[8]  
CHONN A, 1992, J BIOL CHEM, V267, P18759
[9]  
Felgner Jiin, 1993, Methods (Orlando), V5, P67, DOI 10.1006/meth.1993.1009
[10]   Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells [J].
Filion, MC ;
Phillips, NC .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1997, 1329 (02) :345-356
1234